Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2025 | Ethical implementation of artificial intelligence tools in breast cancer

Amrita Basu, PhD, University of California San Francisco, San Francisco, CA, discusses the importance of accountability and transparency in the development and use of artificial intelligence (AI) in breast cancer, highlighting the need for human oversight and verification to ensure the AI’s continuous improvement and accuracy. Setting up teams is important to verify and provide checks and balances on AI results, as well as ensuring representation across different patient cohorts to mitigate bias. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2025 Meeting in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

The technology is moving pretty fast, faster than the governance on AI. So I think that, you know, as we go further on, that there needs to be accountability, transparency. So transparency in terms of how did the AI come up with what it gave us and what results that we’re seeing I think that we really have to think about sort of setting up you know maybe teams that work together on just verifying checks and balances and feeding that back into the AI so that the AI actually can continuously improve...

The technology is moving pretty fast, faster than the governance on AI. So I think that, you know, as we go further on, that there needs to be accountability, transparency. So transparency in terms of how did the AI come up with what it gave us and what results that we’re seeing I think that we really have to think about sort of setting up you know maybe teams that work together on just verifying checks and balances and feeding that back into the AI so that the AI actually can continuously improve. I mean, ultimately, it’s the humans feeding back the information in by doing verification. So I think having a human in the loop and having that transparency and that representation across different cohorts of patients that were not biased, I think all of those kind of risk factors and trying to mitigate that will help us interpret the AI in a much more efficient and accurate way.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...